Cal­i­for­nia up­start Xyphos wants to tack­le CAR-T's big prob­lems

A San Fran­cis­co biotech that’s been de­vel­op­ing an­tibi­otics for the past decade has spun out a new on­col­o­gy start­up that bor­rows ideas from ex­ist­ing CAR …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.